CD274 and neoplasm: Current research mostly focused on single biomarker classes in isolation: e.g. those related to tumor immune evasion (e.g. PD-L1)27–31, inflammation in the tumor microenvironment (e.g. expression profiling of immune cells)31–33, or tumor mutational/neo-antigen burden34, although multi-parameter approaches have also been proposed35.